Plonmarlimab

Plonmarlimab (TJ003234) is an anti-GM-CSF monoclonal antibody. Plonmarlimab can be used for research of rheumatoid arthritis and COVID-19[1][2].

Product Specifications

CAS Number

[2377482-36-3]

Product Name Alternative

TJ003234; TJM2

UNSPSC

12352203

Target

C-Fms; SARS-CoV

Type

Inhibitory Antibodies

Related Pathways

Anti-infection; Protein Tyrosine Kinase/RTK

Applications

COVID-19-anti-virus

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/plonmarlimab.html

Purity

99.82

Solubility

10 mM in DMSO

Smiles

[Plonmarlimab]

Molecular Weight

(145.95 kDa)

References & Citations

[1]Bonaventura A, et al. Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies. Front Immunol. 2020 Jul 3;11:1625. |[2]Bonam SR, et al. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. Cell Rep Med. 2020 May 19;1 (2) :100016.